Press release
Non-Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Pipeline Analysis
Download Sample
Access Report Overview: https://www.psmarketresearch.com/market-analysis/non-alcoholic-fatty-liver-disease-therapeutics-pipeline-analysis
The complications associated with NAFLD are liver failure, cardiovascular disease, and liver cancer. The symptoms observed in patients with NAFLD are nausea, loss of appetite, yellowing of skin and eyes, swelling of legs (leg edema), itching, and abdominal pain. Zydus Discovery DMCC is in the process of developing saroglitazar as a peroxisome proliferator-activated receptor alpha agonist for the treatment of NAFLD. University of California, San Diego is in the process of developing aramchol as a ATP binding cassette transporter I stimulant for the treatment of NAFLD. Some of the companies having the pipeline of NAFLD include AstraZeneca plc, Kowa Company, Ltd., Viking Therapeutics, Inc., and others.
Download Sample of This Research Report: https://www.psmarketresearch.com/market-analysis/non-alcoholic-fatty-liver-disease-therapeutics-pipeline-analysis/report-sample
The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials. Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.
Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=non-alcoholic-fatty-liver-disease-therapeutics-pipeline-analysis
Contact:
Mr. Kundan Kumar
Manager – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +18887787886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Browse more : https://www.psmarketresearch.com/industry-report/pharmaceuticals
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Pipeline Analysis here
News-ID: 824172 • Views: …
More Releases from P&S Market Research
Smart Cities Market Size, Revenue, Technology, Competitive Analysis, Growth Driv …
The global smart cities market is growing at a CAGR above 20% during 2018 - 2023 and will reach $2578.0 billion by 2023. Due to significant growth in automation technologies such as internet of things (IoT) and adoption of cloud based technologies, the global smart cities market is gaining huge traction. In addition, effective city asset management for public welfare, substantial operational cost savings, and automated public data generation applications…
Global Sports Food Market Expected to Witness 9.2% CAGR During 2016 – 2022
The global sports food market is expected to grow at a CAGR of 9.2% in terms of value during 2016 - 2022. Among the various types, the energy bars segment accounted for the largest share (71.5%) in the global sports food market in 2015.
Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/sports-food-market/report-sample
The manufacturers are trying to bring about products with the best blend of taste and healthy ingredients. They have started to…
Sports Nutrition Market by Type, Distribution Channel, Region, Growth and Demand …
The global sports nutrition market is expected to grow at a CAGR of 8.4% in terms of value during 2016 - 2022. Among the various types, the sports drinks segment accounted for largest share (61.4%) in the global sports nutrition market in 2015.
Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/sports-nutrition-market/report-sample
The increasing health concerns, such as obesity and awareness of physical appearances among all consumers groups is driving the demand for sports…
Orthopedic Trauma Devices Market Supply Chain Trends Mapping the Latest Technolo …
The global orthopedic trauma devices market is growing due to the increasing frequency of fractures, along with the growth of aging population. The advantageous features posed by orthopedic trauma devices, such as internal and external fixators to set a fracture, and in repositioning of bone fragments into their normal alignment are also driving the growth of the market worldwide. Furthermore, the internal fixators have reduced the hospital stays, reduced the…
More Releases for NAFLD
Global Fatty Liver Disease Drugs Market By Type (ALD, NAFLD), By Stages of ALD a …
"The Report Global Fatty Liver Disease Drugs Market By Type (ALD, NAFLD), By Stages of ALD and NAFLD, By Region, By Country: Opportunities and Forecast (2017-2022) - By ALD Stages (Alcoholic Steatosis, Alcoholic Steatohepatitis), By NAFLD Stages (Steatosis, NASH) provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
View Sample PDF : https://www.marketresearchreports.biz/reports/1256620/global-fatty-liver-disease-drugs-market-research-reports.pdf
A comprehensive research report created through extensive primary research (inputs…
Global Fatty Liver Disease Drugs Market By Type (ALD, NAFLD), By Stages of ALD a …
"The Report Global Fatty Liver Disease Drugs Market By Type (ALD, NAFLD), By Stages of ALD and NAFLD, By Region, By Country: Opportunities and Forecast (2017-2022) - By ALD Stages (Alcoholic Steatosis, Alcoholic Steatohepatitis), By NAFLD Stages (Steatosis, NASH) provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
View Sample PDF : https://www.marketresearchreports.biz/reports/1256620/global-fatty-liver-disease-drugs-market-research-reports.pdf
A comprehensive research report created through extensive primary research (inputs…
Worldwide Fatty Liver Disease Drugs Industrial and Market studies By Type (ALD, …
"Global Fatty Liver Disease Drugs Market By Type (ALD, NAFLD), By Stages of ALD and NAFLD, By Region, By Country: Opportunities and Forecast (2017-2022) - By ALD Stages (Alcoholic Steatosis, Alcoholic Steatohepatitis), By NAFLD Stages (Steatosis, NASH)" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect.
Description-
-- Executive Summary
A comprehensive research report created through extensive primary research (inputs from industry experts, companies,…
Global Fatty Liver Disease Drugs Market By Type (ALD, NAFLD), By Stages of ALD a …
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Fatty Liver Disease Market on the basis of Type (Alcoholic Fatty Liver Disease or ALD), Non Alcoholic Fatty Liver Disease or NAFLD), By Alcoholic Fatty Liver Stages (Alcoholic Steatosis, Alcoholic Steatohepatitis), By Non Alcoholic Fatty Liver Stages (Non Alcoholic Steatosis, Non Alcoholic Steatohepatitis…
Non Alcoholic Fatty Liver Disease (NAFLD) Research and Development Pipeline Insi …
Albany, New York, August 2, 2017: Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Non Alcoholic Fatty Liver Disease (NAFLD)-Pipeline Insights, 2017” report provides comprehensive insights of the ongoing therapeutic research and development across Non Alcoholic Fatty Liver Disease (NAFLD). The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A…
Global Fatty Liver Disease Drugs Market By Type (ALD, NAFLD), By Stages of ALD a …
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Fatty Liver Disease Market on the basis of Type (Alcoholic Fatty Liver Disease or ALD), Non Alcoholic Fatty Liver Disease or NAFLD), By Alcoholic Fatty Liver Stages (Alcoholic Steatosis, Alcoholic Steatohepatitis), By Non Alcoholic Fatty Liver Stages (Non Alcoholic Steatosis, Non Alcoholic…
